Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10852752 | Biologicals | 2011 | 4 Pages |
Abstract
Even though there seem to be differences in data requirements by each national regulatory authority, the accumulation of experience will provide the rationale and consensus on how to design the clinical trials for follow-on biologics.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Teruyo Arato, Teruhide Yamaguchi,